XML 250 R42.htm IDEA: XBRL DOCUMENT v3.25.0.1

Segment Information (Tables)

12 Months Ended

Dec. 31, 2024

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment

The following table illustrates our segment information for significant operating expenses and includes a reconciliation to net loss for the years ended December 31, 2024 and 2023:

			Year Ended December 31,
			2024						2023
Revenue			$	1,000					$	—
Operating Expenses:
Research and development by significant expense:
BOLSTER trial			3,581						3,517
ASCEND trial			754						1,155
Chemistry, manufacturing and controls			2,035						2,406
Clinical department			4,304						4,744
Other (1)			660						912
Research and development			11,334						12,734
General and administrative by significant expense:
Corporate			3,693						3,856
Investor relations/public relations/communications			1,332						898
Finance			2,265						2,421
Legal			1,284						1,292
Business development			582						1,474
Share based compensation expense			1,383						1,497
Other (2)			1,536						1,536
General and administrative			12,075						12,974
Operating loss			(22,409)						(25,708)
Other income (expense),net			1,626						2,538
Benefit from income taxes			(798)						(2,330)
Net loss			$	(19,985)					$	(20,840)
Cash and marketable securities			$	31,245					$	50,535
(1) Included in other are GBM study, FORTIFIDE study and research      oncology expenses
(2) Included in other are facilities expense, human resource      and information technology expenses

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration